Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02990468 · FLOW

Participant flow

A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer · Source last updated 2023-03-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Participants were administered a 7 mg loading dose followed by a 3.5 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG000
    title
    Phase 1: Group 1
  2. description
    Participants were administered a 14 mg loading dose followed by a 7 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG001
    title
    Phase 1: Group II
  3. description
    Participants were administered a 28 mg loading dose followed by a 14 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG002
    title
    Phase 2: Group III - MTD
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        0
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Phase 1: Dose Escalation
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Change in treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        23
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        22
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Phase 2: MTD
Complete source fields
groups
  1. description
    Participants were administered a 7 mg loading dose followed by a 3.5 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG000
    title
    Phase 1: Group 1
  2. description
    Participants were administered a 14 mg loading dose followed by a 7 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG001
    title
    Phase 1: Group II
  3. description
    Participants were administered a 28 mg loading dose followed by a 14 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.
    id
    FG002
    title
    Phase 2: Group III - MTD
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        0
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        3
      3. group Id
        FG002
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Phase 1: Dose Escalation
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Change in treatment
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        23
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        22
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      NOT COMPLETED
    title
    Phase 2: MTD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice